Lutronic Vision Initiates Preclinical Trial of R:GEN Laser for the Treatment of Dry AMD

Source: Lutronic Vision

Lutronic Vision announced that it has initiated a preclinical trial to determine the optimal setting for its R:GEN laser for the treatment of the dry form of age-related macular degeneration (AMD).  This study has been initiated at the University of Southern California with Stan Louie, PharmD, Professor of Pharmacy, as the Lead Investigator, and Juan Carlos Martinez Camarillo, MD, Assistant Professor of Research Ophthalmology. At the conclusion of this study, Lutronic Vision will be poised to initiate clinical evaluation of the R:GEN laser’s ability to treat dry AMD.

Mark Humayun, MD, PhD, Professor of Ophthalmology and Biomedical Engineering at USC and co-inventor of the Argus II retinal prosthesis, said, “As a clinician-engineer, I look forward to exploring potential treatments for dry AMD in an effort to stop vision loss and help individuals maintain their independence.”

Related Content